Juvenile Idiopathic Arthritis clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • Adalimumab in JIA-associated Uveitis Stopping Trial

    Sorry, in progress, not accepting new patients

    The proposed study is a stratified, block-randomized, double-masked, controlled trial to determine the feasibility of discontinuing adalimumab treatment in patients with quiescent uveitis associated with juvenile idiopathic arthritis (JIA) or chronic anterior uveitis (CAU).

    San Francisco, California and other locations

Our lead scientists for Juvenile Idiopathic Arthritis research studies include .

Last updated: